UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.13 +0.13 (+0.16%) GOLD FUTURES
2,309.40 -1.60 (-0.07%) DOW
38,064.13 +160.84 (+0.42%) Bitcoin GBP
47,159.97 +1,634.10 (+3.59%)
Akoya Biosciences, Inc. (AKYA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:05PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 195.05M |
| Enterprise value | 197.63M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.82 |
| Price/book (mrq) | 3.63 |
| Enterprise value/revenue | 2.05 |
| Enterprise value/EBITDA | -4.33 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.48 |
| 52-week change 3 | -44.15% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 8.8000 |
| 52-week low 3 | 3.0400 |
| 50-day moving average 3 | 4.6454 |
| 200-day moving average 3 | 4.8223 |
Share statistics
| Avg vol (3-month) 3 | 176.16k |
| Avg vol (10-day) 3 | 116.21k |
| Shares outstanding 5 | 49.38M |
| Implied shares outstanding 6 | 49.38M |
| Float 8 | 17.54M |
| % held by insiders 1 | 12.82% |
| % held by institutions 1 | 71.90% |
| Shares short (15 Apr 2024) 4 | 1.01M |
| Short ratio (15 Apr 2024) 4 | 6.92 |
| Short % of float (15 Apr 2024) 4 | 3.39% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.05% |
| Shares short (prior month 15 Mar 2024) 4 | 1.05M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -65.53% |
| Operating margin (ttm) | -33.31% |
Management effectiveness
| Return on assets (ttm) | -19.65% |
| Return on equity (ttm) | -112.72% |
Income statement
| Revenue (ttm) | 96.63M |
| Revenue per share (ttm) | 2.17 |
| Quarterly revenue growth (yoy) | 24.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -47.14M |
| Net income avi to common (ttm) | -63.32M |
| Diluted EPS (ttm) | -1.4300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 83.12M |
| Total cash per share (mrq) | 1.69 |
| Total debt (mrq) | 85.71M |
| Total debt/equity (mrq) | 159.39% |
| Current ratio (mrq) | 3.45 |
| Book value per share (mrq) | 1.10 |
Cash flow statement
| Operating cash flow (ttm) | -50.9M |
| Levered free cash flow (ttm) | -34.04M |
© 2024 Yahoo. All rights reserved.